Design of indomethacin-loaded nanoparticles: Effect of polymer matrix and surfactant

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 3467-3477

  Dupeyrón, Danay ^a   Kawakami, Monique ^a   Ferreira, Adriana M ^a   Cáceres Vélez, Paolin Rocio ^b   Rieumont, Jacques ^c   Azevedo, Ricardo Bentes ^b   Carvalho, José Carlos T ^a  

^a FEDERAL UNIVERSITY OF AMAPÁ   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSITY OF HAVANA   (Cuba)

Author keywords

Enteric polymer; Indomethacin; Nanoparticles; Nonsteroidal anti inflammatory; Polyethylene glycol

Indexed keywords

EUDRAGIT; INDOMETACIN; MACROGOL; NANOCARRIER; POLYMER; POLYSORBATE 80; SURFACTANT;

ARTICLE; BIOLOGICAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG INTERACTION; DRUG SOLUBILITY; EXCIPIENT COMPATIBILITY; IN VITRO STUDY; LIGHT SCATTERING; NANOENCAPSULATION; PARTICLE SIZE; X RAY DIFFRACTION;

ENTERIC POLYMER; INDOMETHACIN; NANOPARTICLES; NONSTEROIDAL ANTI-INFLAMMATORY; POLYETHYLENE GLYCOL;

ABSORPTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY FLUIDS; DIFFUSION; DRUG COMPOUNDING; INDOMETHACIN; NANOCAPSULES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMETHACRYLIC ACIDS; SOLUBILITY;

EID: 84884547446     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S47621     Document Type: Article

References (32)

1. Wen H, Park K, editors. Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. Hoboken, NJ: John Wiley & Sons; 2010.
2. Singh G, Kumar D, Singh M, Sharma D, Kaur S. Emerging Techniques and Challenges in Colon Drug Delivery Systems. Journal of Applied Pharmaceutical Science. 2012;2(3):139.
3. Jones R. Nonsteroidal anti-inflammatory drug prescribing: past, present, and future. Am J Med. 2001;110(1A):4S-7S.
4. Higuchi K, Umegaki E, Watanabe T, et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol. 2009;44(9): 879-888.
5. Green GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone. 2001;3(5):50-60.
6. Sigthorsson G, Simpson RJ, Walley M, et al. COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice. Gastroenterology. 2002;122(7):1913-1923.
7. Mason L, Edwards J, Moore RA, McQuay HJ. Single dose oral indometacin for the treatment of acute postoperative pain. Cochrane Database Syst Rev. 2004;18(4):CD004308.
8. Gallo O, Franchi A, Magnelli L, et al. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis. Neoplasia. 2001;3(1):53-61.
9. Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm. 2005;305(1-2):22-30.
10. Hawkins C, Hanks GW. The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature. J Pain Symptom Manage. 2000;20(2):140-151.
11. Rao PPN, Kabir SN, Mohamed T. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development. Pharmaceuticals. 2010;3(5):1530-1549.
12. Rostom A, Dubé C, Jolicoeur E, Boucher M, Joyce J. Gastro-duodenal ulcers associated with the use of non-steroidal anti-inflammatory drugs: a systematic review of preventive pharmacological interventions. Technology Report no 38. Ottawa: Canadian Coordinating Office for Health Technology Assessment; 2003.
13. Hawkey CJ, Langman MJ. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut. 2003;52(4):600-608.
14. Sinha M, Gautam L, Shukla PK, Kaur P, Sharma S, Singh TP. Current perspectives in NSAID-induced gastropathy. Mediators Inflamm. 2013;2013:258209.
15. Dupeyrón D, Rieumont J, Carvalho JCT. Some applications of current organic molecules for oral drug delivery. Reviews on Advanced Materials Science. 2013;34(1).
16. Gupta RB, Kompella UB. Drugs and the Pharmaceutical Sciences. v159. In: Nanoparticles Technology for Drug Delivery. New York: Taylor & Francis; 2006.
17. Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release. 2005;102(2):313-332.
18. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm. 2008;363(1-2):26-39.
19. Dupeyrón D, Gonzalez M, Sáez V, Ramón J, Rieumont J. Nano-encapsulation of protein by using an enteric polymer as carrier. IEE Proc Nanobiotechnol. 2005;152(5):165-168.
20. González M, Rieumont J, Dupeyrón D, et al. Nanoencapsulation of acetyl salicylic acid within enteric polymer nanoparticles. Rev Adv Mater Sci. 2008;17:71-75.
21. Dupeyrán D, Rieumont J, González M, Castaño VM. Protein Delivery by Enteric Copolymer Nanoparticles. J Dispers Sci Technol. 2009;30(8): 1188-1194.
22. US Pharmacopeial Convention. U.S. Pharmacopeia National Formulary 2011: USP 34 NF 29 (United States Pharmacopeia/National Formulary). United States Pharmacopeial; Supplement edition (February 2011). Twinbrook Parkway, Rockville, MD, USA.
23. Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27(1):1-12.
24. Holmberg K, Jönsson B, Kronberg B, Lindman B, editors. Surfactants and Polymers in Aqueous Solution. 2nd ed. England: John Wiley & Sons; 2002.
25. Silverstein RM, Webster FX, Kiemle D. Spectrometric Identification of Organic Compounds. 7th ed. Hoboken, NJ: John Wiley & Sons; 2005.
26. Tibola APOV. Estudo de compatibilidade entre a izoniazida e excipientes farmacêuticos. [Study of compatibility between izoniazida and pharmaceutical excipients]. Master Thesis. 2009; 1-140.
27. Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res. 1997;14(12):1691-1698.
28. Sunil SA, Srikanth MV, Rao NS, Raju V, Murthy KV. Investigation on in vitro dissolution rate enhancement of indomethacin by using a novel carrier sucrose fatty acid ester. Daru. 2012;20(1):4.
29. Thassu D, Deleers M, Pathak Y, editors. Nanoparticulate Drug Delivery Systems (Drugs and the Pharmaceutical Sciences) (First Edition). Boca Raton, FL: CRC Press; 2007.
30. Karnachi AA, Khan MA. Box-behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures. Int J Pharm. 1996;131(1):9-17.
31. Dupeyrón Martell DR, Rieumont Briones J, González Hurtado M, del Real López A, Castaño Meneses VM. Effect of solvents on the morphological characterization of enteric nanoparticles. Materials Research. 2009;12(4):409-414.
32. Honary S, Majidian A, Naghibi F. The effect of different surfactants on dissolution rate of recrystallized indomethacin. Iranian Journal of Pharmaceutical Research. 2007;6(1):25-33.